Growth Metrics

TriSalus Life Sciences (TLSIW) Receivables - Net (2022 - 2025)

Historic Receivables - Net for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $5.0 million.

  • TriSalus Life Sciences' Receivables - Net rose 179.15% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 179.15%. This contributed to the annual value of $5.1 million for FY2024, which is 4130.56% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Receivables - Net stood at $5.0 million, which was up 179.15% from $5.6 million recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Receivables - Net registered a high of $5.6 million during Q2 2025, and its lowest value of $1.6 million during Q4 2022.
  • Its 4-year average for Receivables - Net is $4.3 million, with a median of $4.8 million in 2024.
  • As far as peak fluctuations go, TriSalus Life Sciences' Receivables - Net surged by 13121.39% in 2023, and later soared by 179.15% in 2025.
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Receivables - Net stood at $1.6 million in 2022, then skyrocketed by 131.21% to $3.6 million in 2023, then skyrocketed by 41.31% to $5.1 million in 2024, then dropped by 1.71% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $5.6 million for Q2 2025, and $5.5 million during Q1 2025.